Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.01
UVIC's Cash to Debt is ranked lower than
57% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. UVIC: 0.01 )
UVIC' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.01

Equity to Asset -0.86
UVIC's Equity to Asset is ranked lower than
57% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. UVIC: -0.86 )
UVIC' s 10-Year Equity to Asset Range
Min: -2.38   Max: 0.91
Current: -0.86

-2.38
0.91
Interest Coverage 11.90
UVIC's Interest Coverage is ranked higher than
63% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. UVIC: 11.90 )
UVIC' s 10-Year Interest Coverage Range
Min: 0.47   Max: 9999.99
Current: 11.9

0.47
9999.99
F-Score: 5
Z-Score: -3.34
M-Score: -2.04
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.83
UVIC's Operating margin (%) is ranked higher than
86% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. UVIC: 16.83 )
UVIC' s 10-Year Operating margin (%) Range
Min: -12.22   Max: 31.86
Current: 16.83

-12.22
31.86
Net-margin (%) 10.24
UVIC's Net-margin (%) is ranked higher than
81% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. UVIC: 10.24 )
UVIC' s 10-Year Net-margin (%) Range
Min: -20.03   Max: 149.13
Current: 10.24

-20.03
149.13
ROA (%) 20.28
UVIC's ROA (%) is ranked higher than
98% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. UVIC: 20.28 )
UVIC' s 10-Year ROA (%) Range
Min: -32.57   Max: 99.69
Current: 20.28

-32.57
99.69
ROC (Joel Greenblatt) (%) 68.97
UVIC's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. UVIC: 68.97 )
UVIC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -71.58   Max: 152.18
Current: 68.97

-71.58
152.18
Revenue Growth (%) 10.20
UVIC's Revenue Growth (%) is ranked higher than
81% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. UVIC: 10.20 )
UVIC' s 10-Year Revenue Growth (%) Range
Min: -4.8   Max: 36.5
Current: 10.2

-4.8
36.5
EBITDA Growth (%) -4.90
UVIC's EBITDA Growth (%) is ranked higher than
64% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. UVIC: -4.90 )
UVIC' s 10-Year EBITDA Growth (%) Range
Min: -50.4   Max: 181.9
Current: -4.9

-50.4
181.9
EPS Growth (%) -6.60
UVIC's EPS Growth (%) is ranked higher than
66% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. UVIC: -6.60 )
UVIC' s 10-Year EPS Growth (%) Range
Min: -38.3   Max: 20.5
Current: -6.6

-38.3
20.5
» UVIC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with UVIC



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 18.00
UVIC's P/E(ttm) is ranked higher than
83% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. UVIC: 18.00 )
UVIC' s 10-Year P/E(ttm) Range
Min: 0.5   Max: 19.27
Current: 18

0.5
19.27
P/S 1.70
UVIC's P/S is ranked higher than
72% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. UVIC: 1.70 )
UVIC' s 10-Year P/S Range
Min: 0.53   Max: 3.88
Current: 1.7

0.53
3.88
PFCF 19.30
UVIC's PFCF is ranked higher than
80% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. UVIC: 19.30 )
UVIC' s 10-Year PFCF Range
Min: 3.33   Max: 20.72
Current: 19.3

3.33
20.72
EV-to-EBIT 13.20
UVIC's EV-to-EBIT is ranked higher than
81% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. UVIC: 13.20 )
UVIC' s 10-Year EV-to-EBIT Range
Min: 3.2   Max: 2313
Current: 13.2

3.2
2313
PEG 30.20
UVIC's PEG is ranked lower than
69% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. UVIC: 30.20 )
UVIC' s 10-Year PEG Range
Min: 0.31   Max: 31
Current: 30.2

0.31
31
Shiller P/E 12.80
UVIC's Shiller P/E is ranked higher than
96% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. UVIC: 12.80 )
UVIC' s 10-Year Shiller P/E Range
Min: 4.12   Max: 13.81
Current: 12.8

4.12
13.81

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.90
UVIC's Dividend Yield is ranked higher than
95% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. UVIC: 2.90 )
UVIC' s 10-Year Dividend Yield Range
Min: 1.32   Max: 13.24
Current: 2.9

1.32
13.24
Dividend Payout 0.54
UVIC's Dividend Payout is ranked higher than
51% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. UVIC: 0.54 )
UVIC' s 10-Year Dividend Payout Range
Min: 0.21   Max: 1.5
Current: 0.54

0.21
1.5
Dividend growth (3y) -37.00
UVIC's Dividend growth (3y) is ranked higher than
60% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. UVIC: -37.00 )
UVIC' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 17
Current: -37

0
17
Yield on cost (5-Year) 0.44
UVIC's Yield on cost (5-Year) is ranked lower than
67% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. UVIC: 0.44 )
UVIC' s 10-Year Yield on cost (5-Year) Range
Min: 0.2   Max: 2.03
Current: 0.44

0.2
2.03
Share Buyback Rate 13.00
UVIC's Share Buyback Rate is ranked higher than
97% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. UVIC: 13.00 )
UVIC' s 10-Year Share Buyback Rate Range
Min: 19.6   Max: -5.6
Current: 13

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.50
UVIC's Price/DCF (Projected) is ranked higher than
97% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. UVIC: 0.50 )
UVIC' s 10-Year Price/DCF (Projected) Range
Min: 0.23   Max: 3.58
Current: 0.5

0.23
3.58
Price/Median PS Value 1.00
UVIC's Price/Median PS Value is ranked higher than
92% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. UVIC: 1.00 )
UVIC' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 2
Current: 1

0.01
2
Price/Peter Lynch Fair Value 1.90
UVIC's Price/Peter Lynch Fair Value is ranked higher than
55% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. UVIC: 1.90 )
UVIC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.03   Max: 1.58
Current: 1.9

0.03
1.58
Earnings Yield (Greenblatt) 7.60
UVIC's Earnings Yield (Greenblatt) is ranked higher than
81% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. UVIC: 7.60 )
UVIC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 31.7
Current: 7.6

0.1
31.7
Forward Rate of Return (Yacktman) 18.06
UVIC's Forward Rate of Return (Yacktman) is ranked higher than
92% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UVIC: 18.06 )
UVIC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -17.7   Max: 23.8
Current: 18.06

-17.7
23.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UVI.Canada
Unilens Vision, Inc. was incorporated in 1989, to the State of Delaware on April 1, 2010. The company licenses, manufacture, distribute and market specialty optical lens products using proprietary design and manufacturing technology. Its products are sold primarily in the United States solely to eye care professionals through in house sales representatives, independent sales brokers and a network of distributors. Its lens products are marketed as a family of specialty vision correction products that can serve the majority of the population's vision correction needs. Its specialty optical lens business is divided into four categories: (i) disposable lenses; (ii) custom soft lenses; (iii) gas permeable lenses; and (iv) replacement and other lenses. Its disposable lenses line consists of the C-Vue, a mulitfocal cast molded blister-packed box of six lenses sold for frequent replacement, the C-Vue Aspheric single vision lens, a single vision disposable soft contact lens sold for 2-week replacement and the C-Vue 1 Day Aspheric single vision daily disposable soft contact lens sold for one day wear then just simply thrown away. The C-Vue multifocal lens is manufactured for it by a third party utilizing one of its patented soft lens designs and is marketed exclusively in the United States to eye care professionals. The cast molded C-Vue Aspheric single vision lens and the C-Vue 1 Day Aspheric single vision lens are each manufactured for it by a third party utilizing Wavefront inspired technology. The company markets the C-Vue Aspheric single vision lens in a blister-packed box of six lenses and the C-Vue 1 Day Aspheric single vision lens in blister-packs of 30 and 90 lenses. Its custom soft lenses line of soft lathe-cut products includes the C-Vue Toric Multifocal, designed for patients with an astigmatism that require bifocal correction, the C-Vue Custom Toric and the C-Vue 55 multifocal, a high-add multifocal, manufactured in a comfortable high-water content material, all available in its Advanced line of biocompatible materials. Its gas permeable lens line of products consist of the Unilens GP, a multifocal contact lens intended for patients with astigmatism who need low to moderate presbyopic correction; the Unilens GP Plus, designed to accommodate wearers requiring presbyopic correction; the C-Vue GP, a front aspheric design incorporating the C-Vue design technology and the C-Ray GP utilizing its recently patented design technology, featuring an on eye ray traced power profile over an elliptical base. Its replacement and other lenses line of products primarily consists of the Unilens, an aspheric multifocal contact lens; the SoftSite, a highadd multifocal contact lens; the SimulVue, a simultaneous vision bifocal contact lens with the capabilities for correcting advanced presbyopia; the Unilens EMA, a visibility tinted multifocal contact lens available in planned replacement modality; the LifeStyle brand of toric multifocal, toric and
» More Articles for UVIC

Headlines

Articles On GuruFocus.com
comment on UVIC Nov 15 2012 

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide